Chinese Pharmaceuticals & Biotech Sustainable Track Record

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

6 companies

Henan Lingrui Pharmaceutical

Market Cap: CN¥12.7b

Produces and sells medicines in China.

600285

CN¥22.63

0.1%

2.0%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥39.4b

Shanghai Allist Pharmaceuticals Co., Ltd.

688578

CN¥87.45

-2.1%

89.2%

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥12.9b

Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.

300573

CN¥73.50

-6.0%

-54.1%

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥20.4b

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.

600329

CN¥30.38

-3.4%

-3.8%

Xiamen Amoytop Biotech

Market Cap: CN¥31.2b

Engages in research, development, production, and sale of recombinant protein drugs in China.

688278

CN¥76.61

-2.2%

21.2%

Hunan Jiudian Pharmaceutical

Market Cap: CN¥8.3b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

300705

CN¥16.82

-10.4%

-32.9%